A Vela1, G Pérez-Nanclares1, I Ríos1, I Rica1, N Portillo2, L Castaño3. 1. Biocruces Health Research Institute, Cruces University Hospital, CIBERER, CIBERDEM, UPV-EHU, Barakaldo, Basque Country, Spain. 2. Biocruces Health Research Institute, Alto Deba Hospital, Gipuzkoa, Basque Country, Spain. 3. Biocruces Health Research Institute, Cruces University Hospital, CIBERER, CIBERDEM, UPV-EHU, Barakaldo, Basque Country, Spain. lcastano@osakidetza.net.
Abstract
OBJECTIVE: Thyroid hormone resistance (RTH β) is a rare genetic disorder characterized by an altered response of target tissue to the action of thyroid hormone. Few studies on RTH β have been carried out in southern European populations. We aimed to describe the clinical and genetic characteristics at the time of diagnosis in a Spanish cohort of patients with genetically confirmed RTH β, with ages ranging from newborns to adults. METHODS: Retrospective multicenter study of 28 patients who were genetically confirmed as RTH β. Clinical and biochemical data were collected from the reference centers, and the studied variables included age, sex, anthropometric data, clinical characteristics and biochemical results. In the Basque country, a simultaneous analysis of TSH and T4 is carried out in the program for the screening of inborn errors of metabolism. A molecular analysis of the thyroid hormone beta (THRB) gene was performed. RESULTS: The total cohort included 20 adults and eight pediatric patients (six newborns). Of the total, 5 (17.8%) were diagnosed by clinical characteristics (goiter, hypertension or tachycardia), 13 (46.4%) were analyzed in the context of a family study and 10 (35.7%) were diagnosed after obtaining an altered fT4 and/or TSH level in a biochemical analysis performed due to clinical symptoms unrelated to RTH β. Four of the newborns included in the series were diagnosed by the result of neonatal screening, which allows us to estimate a minimum local incidence of RTH β of 1/18,750 live newborns. The genetic analysis showed the presence of 12 different heterozygous mutations in the THRB gene. CONCLUSIONS: We report the clinical and genetic characteristics of a Spanish RTH β cohort, from neonates to adults. We also describe one novel mutation in the THRB gene as the cause of the disease. The simultaneous analysis of TSH and T4 carried out in the program for the screening of inborn errors of metabolism facilitates the early diagnosis of RTH β in newborns and has allowed us to estimate a minimum local incidence of RTH of 1/18,750 live newborns.
OBJECTIVE: Thyroid hormone resistance (RTH β) is a rare genetic disorder characterized by an altered response of target tissue to the action of thyroid hormone. Few studies on RTH β have been carried out in southern European populations. We aimed to describe the clinical and genetic characteristics at the time of diagnosis in a Spanish cohort of patients with genetically confirmed RTH β, with ages ranging from newborns to adults. METHODS: Retrospective multicenter study of 28 patients who were genetically confirmed as RTH β. Clinical and biochemical data were collected from the reference centers, and the studied variables included age, sex, anthropometric data, clinical characteristics and biochemical results. In the Basque country, a simultaneous analysis of TSH and T4 is carried out in the program for the screening of inborn errors of metabolism. A molecular analysis of the thyroid hormone beta (THRB) gene was performed. RESULTS: The total cohort included 20 adults and eight pediatric patients (six newborns). Of the total, 5 (17.8%) were diagnosed by clinical characteristics (goiter, hypertension or tachycardia), 13 (46.4%) were analyzed in the context of a family study and 10 (35.7%) were diagnosed after obtaining an altered fT4 and/or TSH level in a biochemical analysis performed due to clinical symptoms unrelated to RTH β. Four of the newborns included in the series were diagnosed by the result of neonatal screening, which allows us to estimate a minimum local incidence of RTH β of 1/18,750 live newborns. The genetic analysis showed the presence of 12 different heterozygous mutations in the THRB gene. CONCLUSIONS: We report the clinical and genetic characteristics of a Spanish RTH β cohort, from neonates to adults. We also describe one novel mutation in the THRB gene as the cause of the disease. The simultaneous analysis of TSH and T4 carried out in the program for the screening of inborn errors of metabolism facilitates the early diagnosis of RTH β in newborns and has allowed us to estimate a minimum local incidence of RTH of 1/18,750 live newborns.
Entities:
Keywords:
Early diagnosis of RTH β; RTH β management; Resistance to thyroid hormones; Spanish cohort; THRB gene
Authors: P Torre; M Bertoli; S Di Giovanni; S Scommegna; C Conte; G Novelli; S Cianfarani Journal: J Endocrinol Invest Date: 2005 Jul-Aug Impact factor: 4.256
Authors: C A Meier; B M Dickstein; K Ashizawa; J H McClaskey; P Muchmore; S C Ransom; J B Menke; E H Hao; S J Usala; B B Bercu Journal: Mol Endocrinol Date: 1992-02
Authors: C Asteria; O Rajanayagam; T N Collingwood; L Persani; R Romoli; D Mannavola; P Zamperini; F Buzi; F Ciralli; V K Chatterjee; P Beck-Peccoz Journal: J Clin Endocrinol Metab Date: 1999-02 Impact factor: 5.958
Authors: Stephen H Lafranchi; David B Snyder; David E Sesser; Michael R Skeels; Nalini Singh; Gregory A Brent; Jerald C Nelson Journal: J Pediatr Date: 2003-09 Impact factor: 4.406
Authors: Rossella Cannarella; Marco Musmeci; Vincenzo Garofalo; Tiziana A Timpanaro; Guido Leone; Manuela Caruso; Paolo E Maltese; Rosita A Condorelli; Sandro La Vignera; Aldo E Calogero Journal: Int J Mol Sci Date: 2022-09-24 Impact factor: 6.208